Skip to main content

Health & Medicine

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.

marketwatch.com ·2026-09-22

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.

Also reported by 3 other outlets

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month marketwatch.com
Dozens of people sue GLP-1 drug companies over alleged vision loss aljazeera.com
Viking Therapeutics (VKTX) Rockets 35.7% After Weight Loss Drug Trial — What’s The Selling Point? finance.yahoo.com

Read the original at marketwatch.com →

More in Health & Medicine

Celldex sinks as safety concerns cloud immune drug results

Though barzolvolimab displayed what one analyst described as the best efficacy results to date against chronic skin hives, treatment was also associated with two life-threatening anaphylaxis cases.

2026-09-22 ·biopharmadive.com

Immune cells that may help sustain type 1 diabetes attack identified

Type 1 diabetes isn't an overnight attack against the body's ability to make insulin. It can be a sustained campaign over years that relentlessly targets insulin-producing cells in the pancreas.

2026-09-22 ·medicalxpress.com

Most kids bounced back after COVID disruptions

Long-term research finds most children recovered from the effects of the pandemic.

2026-09-22 ·futurity.org

I started drinking at 12. It took multiple DUIs, serious health issues, and homelessness for me to quit at 44.

Katie Rosier began drinking at 12. She got sober 32 years later, after DUIs, serious health issues, and time in a homeless shelter.

2026-09-22 ·businessinsider.com

Y chromosome loss could be early cancer sign for men

"We were able to show that the loss of the Y chromosome is found in normal appearing tissues adjacent to a tumor."

2026-09-22 ·futurity.org

Lindsay Clancy Family Friend Says Patrick Interview Was ‘Missed Opportunity’

Brittany Romano says Patrick Clancy's "60 Minutes" interview missed key questions and overlooked postpartum psychosis.

Lindsay Clancy's friend criticizes Patrick's 60 Minutes interview as a missed opportunity.
Interview lacked key questions about postpartum psychosis and mental health awareness.
Brittany Romano felt Clancy should focus on raising awareness and supporting his grieving process.

2026-09-22 ·newsweek.com

More from Tuesday 22 September →